brman- $14/sh p1 of spreadsheet with low multiples and patient size. Buyout multiples may vary of course.
You will see much higher traded companies with less (o8> so the issue for CYDY is more it's unknown status.
We know it looks unreal from here, but I have also posted the references of usual multiples of sector and peers incl TaiMed.
Insanely cheap indeed, but that is how the market deals with certain stocks. Some are insanely overvalued and some the other way around. Therefor a market correction is expected the more credible company becomes, i.e. data data data.
Market Data 
Markets 
AI
